DekaBank Deutsche Girozentrale’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,690	Closed	-$1.48M	–	1437
2021 Q1	$1.48M	Hold	12,690	–	–	﹤0.01%	780
2020 Q4	$1.48M	Buy	12,690 +1,850	+17%	+$215K	0.01%	748
2020 Q3	$1.18M	Buy	+10,840	New	+$1.16M	0.01%	714
2017 Q3	–	Sell	-12,730	Closed	-$1.42M	–	1059
2017 Q2	$1.42M	Hold	12,730	–	–	0.01%	622
2017 Q1	$1.27M	Sell	12,730 -1,090	-8%	-$116K	0.01%	569
2016 Q4	$1.51M	Buy	13,820 +1,040	+8%	+$122K	0.02%	480
2016 Q3	$1.58M	Hold	12,780	–	–	0.02%	476
2016 Q2	$1.35M	Buy	12,780 +1,360	+12%	+$158K	0.02%	510
2016 Q1	$1.3M	Buy	+11,420	New	+$1.34M	0.02%	512

DekaBank Deutsche Girozentrale's CBPO Position: Q2 2021 in Review

DekaBank Deutsche Girozentrale sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 12,690 shares — an estimated $1.48M sold.

DekaBank Deutsche Girozentrale first reported a position in CBPO in Q1 2016 and held it in 9 quarters. The position peaked at $1.58M in Q3 2016. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

DekaBank Deutsche Girozentrale reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 12,690 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $1.48M.
DekaBank Deutsche Girozentrale first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 9 quarters.
DekaBank Deutsche Girozentrale's China Biologic Products Holdings, Inc. position peaked at $1.58M in Q3 2016.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.